ORYX GmbH & Co. KG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.oryx-medicine.com
Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer
Phase 1
Completed
- Conditions
- Carcinoma, Pancreatic Ductal
- Interventions
- Drug: Parvovirus H-1 (H-1PV)
- First Posted Date
- 2016-01-12
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Oryx GmbH & Co. KG
- Target Recruit Count
- 7
- Registration Number
- NCT02653313
- Locations
- 🇩🇪
National Center for Tumor Diseases (NCT), Heidelberg, Baden-Württemberg, Germany
Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers
Phase 1
Completed
- Conditions
- HPV-induced Cancers
- Interventions
- Biological: P16_37-63 peptide combined with Montanide® ISA-51 VGBiological: P16_37-63 peptide without Montanide® ISA-51 VG
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Oryx GmbH & Co. KG
- Target Recruit Count
- 11
- Registration Number
- NCT02526316
- Locations
- 🇩🇪
Krankenhaus Nordwest, Frankfurt, Germany
Immune Therapy of HPV-induced Cancers
Phase 1
Completed
- Conditions
- HPV-induced Cancers
- Interventions
- Biological: P16_37-63
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2015-06-23
- Lead Sponsor
- Oryx GmbH & Co. KG
- Target Recruit Count
- 26
- Registration Number
- NCT01462838
- Locations
- 🇩🇪
Krankenhaus Nordwest, Frankfurt/Main, Germany
Vaccination Against MSI Colorectal Cancer
Phase 1
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Biological: FSP peptides
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2015-06-23
- Lead Sponsor
- Oryx GmbH & Co. KG
- Target Recruit Count
- 22
- Registration Number
- NCT01461148
- Locations
- 🇩🇪
Krankenhaus Nordwest, Frankfurt/Main, Germany
Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Oryx GmbH & Co. KG
- Target Recruit Count
- 18
- Registration Number
- NCT01301430
- Locations
- 🇩🇪
Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany
© Copyright 2025. All Rights Reserved by MedPath